"Meanwhile big pharma is progressing expansive clinical trials...

"Meanwhile big pharma is progressing expansive clinical trials using at times far less impressive oncology, to hundreds if not thousands of patients at a time. Securing enough meaningful data to ensure they obtain FDA approvals as they go."

Can you please point me to a Phase 1b or Phase 2 trial that has hundreds if not thousands of patients? Can you also please point me to breakthrough therapy trials that have not been subject to careful FDA scrutiny regarding safety and efficacy first? I think you would be better pointing your comments at the big pharma executives that have failed recognise the potential of Imugene rather than the executives of IMU that are, no doubt, pushing the field of immuno-oncology forward every day including on the commercial side of the equation.